Top 10 Performing Stocks To Invest In Right Now

tags:FRO,XEL,UVE,HIO,JBSS,XELB,ACLS,TBPH,FHN,LH,

What's it going to take for gold market timers to throw in the towel and turn solidly bearish?

I ask because, even though gold GCQ8, -0.52%  has been performing dismally, the typical gold timer I monitor has become only mildly bearish. According to contrarian analysis, a low-risk buying opportunity won't come until gold timers are aggressively pessimistic and despondent.

Top 10 Performing Stocks To Invest In Right Now: Frontline Ltd.(FRO)

Advisors' Opinion:

• [By Lisa Levin] Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) jumped 124.8 percent to $243.725 in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks. Viking Therapeutics, Inc. (NASDAQ: VKTX) gained 63.4 percent to $8.12 after falling 4.42 percent on Wednesday. Takung Art Co., Ltd. (NYSE: TKAT) rose 43.3 percent to $2.9094 vTv Therapeutics Inc. (NASDAQ: VTVT) shares climbed 29.7 percent to $2.16 after the company reported a licensing deal with Newsoara Biopharma to rights for vTv's PDE4 Inhibitor in China and other Pacific Rim territories. Akers Biosciences, Inc. (NASDAQ: AKER) gained 26.2 percent to $0.4109. The developer of rapid health information technologies said Wednesday afternoon it was granted a 180-day extension from the Nasdaq Stock Market to meet the requirement of a minimum $1.00 per share closing bid price for 10 straight days. Genprex, Inc. (NASDAQ: GNPX) rose 22.2 percent to $11.6254. Genprex reported engagement of WIRB-Copernicus Group to provide clinical trial services to support Oncoprex clinical trial program. J.Jill, Inc. (NYSE: JILL) gained 21 percent to $7.506 after the company posted upbeat quarterly earnings. Urban One, Inc. (NASDAQ: UONE) gained 19.7 percent to $3.95 after rising 78.38 percent on Wednesday. TapImmune, Inc. (NASDAQ: TPIV) shares gained 18.5 percent to $6.03 after climbing 24.15 percent on Wednesday. Kirkland's, Inc. (NASDAQ: KIRK) rose 17.3 percent to $12.95 after reporting upbeat Q1 results. CymaBay Therapeutics, Inc. (NASDAQ: CBAY) shares gained 15.1 percent to $13.210. The Brink's Company (NYSE: BCO) climbed 14.2 percent to $77.875 as the company announced plans to acquire Dunbar Armored for $520 million in cash. Keysight Technologies, Inc. (NYSE: KEY
• [By Matthew DiLallo]

  Shares of Frontline Ltd. (NYSE:FRO) surged more than 13% by 10:00 a.m. EDT on Thursday after the oil tanker company posted better-than-expected first-quarter results.

• [By Lisa Levin] Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) rose 65.5 percent to $179.50 in pre-market trading. Madrigal Pharma disclosed that MGL-3196 achieved liver biopsy endpoints in patients with NASH at 36 weeks in Phase 2 trial. Viking Therapeutics, Inc. (NASDAQ: VKTX) rose 34.8 percent to $6.70 in pre-market trading after falling 4.42 percent on Wednesday. vTv Therapeutics Inc. (NASDAQ: VTVT) shares rose 31.5 percent to $2.19 in pre-market trading after the company reported a licensing deal with Newsoara Biopharma to rights for vTv's PDE4 Inhibitor in China and other Pacific Rim territories. Curis, Inc. (NASDAQ: CRIS) shares rose 27.2 percent to $2.90 in pre-market trading after the company reported FDA Fast Track designation for CUDC-907 development in patients with relapse, refractory diffuse large B-cell lymphoma. Kitov Pharma Ltd (NASDAQ: KTOV) rose 16.7 percent to $2.51 in pre-market trading. Tilly's, Inc. (NYSE: TLYS) rose 14.7 percent to $14.00 in pre-market trading as the company reported better-than-expected earnings for its first quarter and issued a strong Q2 outlook. Express, Inc. (NYSE: EXPR) rose 14.3 percent to $10.49 in pre-market trading after the company reported better-than-expected results for its first quarter. NGL Energy Partners LP (NYSE: NGL) rose 12.8 percent to $12.10 in pre-market trading after reporting Q4 earnings beat. J.Jill, Inc. (NYSE: JILL) rose 11.3 percent to $6.90 in pre-market trading after the company posted upbeat quarterly earnings. TapImmune, Inc. (NASDAQ: TPIV) shares rose 10 percent to $5.60 in pre-market trading after climbing 24.15 percent on Wednesday. Frontline Ltd. (NYSE: FRO) rose 9.8 percent to $5.74 in pre-market trading after Q1 results beat estimates. Tech Data Corporation (NASDAQ: TECD) rose 8.8 percent to $89.65 in pre-market trading following better-than-expected Q1 earnings. TransEnterix, Inc. (NYSE: TRXC) shares rose 7.1 percent to $3.65 in pre-market tra

Top 10 Performing Stocks To Invest In Right Now: Xcel Energy Inc.(XEL)

Advisors' Opinion:

• [By Ethan Ryder]

  Here are some of the media headlines that may have impacted Accern Sentiment Analysis’s rankings:

  Get Xcel Energy alerts: Xcel Energy: Be prepared, stay safe, when severe weather strikes (everythinglubbock.com) Endesa (ELEZF) and Xcel Energy (XEL) Head-To-Head Comparison (americanbankingnews.com) Xcel Energy Inc (XEL) Receives Average Rating of “Buy” from Brokerages (americanbankingnews.com) Xcel Energy (XEL) Shares Enter Oversold Territory (nasdaq.com)

  Shares of XEL stock traded up $0.35 on Friday, hitting $45.19. The stock had a trading volume of 2,477,944 shares, compared to its average volume of 3,484,859. The company has a current ratio of 0.87, a quick ratio of 0.68 and a debt-to-equity ratio of 1.27. Xcel Energy has a 12-month low of $41.51 and a 12-month high of $52.22.

• [By Max Byerly]

  Elastic (XEL) uses the hashing algorithm. It was first traded on June 8th, 2017. Elastic’s total supply is 100,000,000 coins and its circulating supply is 91,676,277 coins. The official website for Elastic is www.elastic.pw. Elastic’s official Twitter account is @elastic_coin. The Reddit community for Elastic is /r/XEL and the currency’s Github account can be viewed here. Elastic’s official message board is talk.elasticexplorer.org.

• [By Max Byerly]

  Nomura Asset Management Co. Ltd. lifted its stake in Xcel Energy Inc (NYSE:XEL) by 2.1% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 225,167 shares of the utilities provider’s stock after purchasing an additional 4,527 shares during the quarter. Nomura Asset Management Co. Ltd.’s holdings in Xcel Energy were worth $10,240,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Top 10 Performing Stocks To Invest In Right Now: UNIVERSAL INSURANCE HOLDINGS INC(UVE)

Advisors' Opinion:

• [By Jon C. Ogg]

  Universal Insurance Holdings Inc. (NYSE: UVE) was down 3.2% at $44.65, in a 52-week range of $19.55 to $46.26.

  United Insurance Holdings Corp. (NASDAQ: UIHC) was down 1.9% at $20.45. Its 52-week range is $14.55 to $22.23.

• [By Logan Wallace]

  These are some of the media stories that may have effected Accern’s scoring:

  Get Universal Insurance alerts: Should You Buy Universal Insurance Holdings Inc (NYSE:UVE) At US$035.15? (finance.yahoo.com) Analyzing Universal Insurance (UVE) and Infinity Property and Casualty (IPCC) (americanbankingnews.com) Why Fundamental Investors Love Universal Insurance Holdings Inc (NYSE:UVE) (finance.yahoo.com) Universal Insurance Holdings, Inc. (NYSE:UVE) Stock Under Examination – Week Performance is -3.2876713 (stocknewscaller.com)

  A number of equities research analysts have recently commented on UVE shares. ValuEngine cut shares of Universal Insurance from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, March 7th. Keefe, Bruyette & Woods set a $35.00 target price on shares of Universal Insurance and gave the company a “buy” rating in a research report on Tuesday, April 10th.

• [By Joseph Griffin]

  Universal Insurance Holdings, Inc. (NYSE:UVE) CEO Sean P. Downes sold 20,000 shares of the company’s stock in a transaction on Thursday, May 24th. The shares were sold at an average price of $35.77, for a total transaction of $715,400.00. Following the completion of the transaction, the chief executive officer now owns 1,479,141 shares in the company, valued at $52,908,873.57. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

• [By Steve Symington]

  As for individual stocks, GoPro (NASDAQ:GPRO) extended Friday's gains amid optimism for the action camera and drone specialist's ongoing turnaround, while shares of Universal Insurance Holdings (NYSE:UVE) rallied on news of the waning storm in Florida.

• [By Joseph Griffin]

  Stifel Financial Corp increased its holdings in shares of Universal Insurance Holdings, Inc. (NYSE:UVE) by 6.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 41,592 shares of the insurance provider’s stock after buying an additional 2,510 shares during the quarter. Stifel Financial Corp owned 0.12% of Universal Insurance worth $1,317,000 as of its most recent SEC filing.

Top 10 Performing Stocks To Invest In Right Now: Western Asset High Income Opportunity Fund, Inc.(HIO)

Advisors' Opinion:

• [By Ethan Ryder]

  Media headlines about Western Asst High Incm Opprtnty Fnd (NYSE:HIO) have trended positive on Monday, according to Accern. Accern ranks the sentiment of news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Western Asst High Incm Opprtnty Fnd earned a news impact score of 0.36 on Accern’s scale. Accern also gave media stories about the closed-end fund an impact score of 46.8812467861134 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

• [By Logan Wallace]

  Headlines about Western Asset High Income (NYSE:HIO) have been trending positive this week, according to Accern Sentiment. The research group scores the sentiment of press coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Western Asset High Income earned a coverage optimism score of 0.49 on Accern’s scale. Accern also assigned press coverage about the closed-end fund an impact score of 47.4682522681889 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

Top 10 Performing Stocks To Invest In Right Now: John B. Sanfilippo & Son, Inc.(JBSS)

Advisors' Opinion:

• [By Max Byerly]

  John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS) shares reached a new 52-week high and low during trading on Wednesday . The stock traded as low as $71.43 and last traded at $70.96, with a volume of 1305 shares trading hands. The stock had previously closed at $69.72.

• [By Max Byerly]

  The Hershey (NYSE: HSY) and John B. Sanfilippo & Son (NASDAQ:JBSS) are both consumer staples companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, analyst recommendations, earnings, valuation and profitability.

• [By Logan Wallace]

  Legal & General Group Plc increased its position in shares of John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS) by 6.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 17,366 shares of the company’s stock after acquiring an additional 1,126 shares during the quarter. Legal & General Group Plc owned about 0.15% of John B. Sanfilippo & Son worth $1,300,000 as of its most recent SEC filing.

Top 10 Performing Stocks To Invest In Right Now: Xcel Brands, Inc(XELB)

Advisors' Opinion:

• [By Shane Hupp]

  Digital Turbine (NASDAQ: APPS) and XCel Brands (NASDAQ:XELB) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, earnings, profitability, institutional ownership and dividends.

• [By Max Byerly]

  Get a free copy of the Zacks research report on XCel Brands (XELB)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Performing Stocks To Invest In Right Now: Axcelis Technologies Inc.(ACLS)

Advisors' Opinion:

• [By ]

  3. Axcelis Technologies (Nasdaq: ACLS)
  It is the technical price pattern that first caught my eye with this $800 million market cap small cap.  Shares dropped to a $22.00 low in mid-February but have since been slowly and steadily moving higher toward resistance at both the 50- and 200-day SMAs. In and of itself, this is not enough impetus to get long. However, when combined with the fundamental picture, a compelling long thesis emerges.

• [By Motley Fool Transcribing]

  Axcelis Technologies (NASDAQ:ACLS) Q4 2018 Earnings Conference CallFeb. 7, 2019 8:30 a.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

• [By Shane Hupp]

  Get a free copy of the Zacks research report on Axcelis Technologies (ACLS)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Stephan Byrd]

  Get a free copy of the Zacks research report on Axcelis Technologies (ACLS)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Performing Stocks To Invest In Right Now: Theravance Biopharma, Inc.(TBPH)

Advisors' Opinion:

• [By Shane Hupp]

  Get a free copy of the Zacks research report on Theravance Biopharma (TBPH)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By Max Byerly]

  Theravance Biopharma (NASDAQ:TBPH) – Investment analysts at Cantor Fitzgerald issued their FY2019 earnings estimates for shares of Theravance Biopharma in a research note issued to investors on Tuesday, May 22nd. Cantor Fitzgerald analyst L. Chen anticipates that the biopharmaceutical company will earn ($3.74) per share for the year. Cantor Fitzgerald currently has a “Buy” rating and a $55.00 price target on the stock.

• [By Max Byerly]

  Theravance Biopharma Inc (NASDAQ:TBPH) has received an average recommendation of “Hold” from the nine research firms that are presently covering the company, Marketbeat.com reports. Two analysts have rated the stock with a sell recommendation, two have given a hold recommendation and five have assigned a buy recommendation to the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is $41.33.

• [By Stephan Byrd]

  Old West Investment Management LLC trimmed its position in Theravance Biopharma Inc (NASDAQ:TBPH) by 4.0% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 109,320 shares of the biopharmaceutical company’s stock after selling 4,542 shares during the period. Theravance Biopharma accounts for approximately 1.5% of Old West Investment Management LLC’s investment portfolio, making the stock its 25th biggest holding. Old West Investment Management LLC owned about 0.20% of Theravance Biopharma worth $2,651,000 at the end of the most recent reporting period.

• [By Logan Wallace]

  Get a free copy of the Zacks research report on Theravance Biopharma (TBPH)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Performing Stocks To Invest In Right Now: First Horizon National Corporation(FHN)

Advisors' Opinion:

• [By Logan Wallace]

  Wells Fargo & Company MN boosted its stake in First Horizon National Corp (NYSE:FHN) by 18.3% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,983,735 shares of the financial services provider’s stock after acquiring an additional 307,297 shares during the period. Wells Fargo & Company MN owned about 0.61% of First Horizon National worth $35,390,000 as of its most recent SEC filing.

• [By Logan Wallace]

  First Horizon National (NYSE:FHN) will be posting its quarterly earnings results before the market opens on Thursday, July 12th.

  First Horizon National (NYSE:FHN) last posted its earnings results on Friday, April 13th. The financial services provider reported $0.34 EPS for the quarter, topping the Zacks’ consensus estimate of $0.30 by $0.04. First Horizon National had a return on equity of 9.37% and a net margin of 12.30%. The business had revenue of $437.20 million for the quarter, compared to analysts’ expectations of $438.60 million. During the same quarter in the previous year, the firm earned $0.23 earnings per share. The business’s revenue was up 42.6% compared to the same quarter last year. On average, analysts expect First Horizon National to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

• [By Shane Hupp]

  Franklin Resources Inc. lifted its position in shares of First Horizon National Corp (NYSE:FHN) by 1.5% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 16,153,527 shares of the financial services provider’s stock after buying an additional 241,452 shares during the quarter. Franklin Resources Inc. owned approximately 4.94% of First Horizon National worth $304,171,000 at the end of the most recent quarter.

• [By ]

  In an "Executive Decision" segment, Cramer sat down with Bryan Jordan, chairman, president and CEO of First Horizon National (FHN) , the Tennessee-based regional bank that just posted a three-cents-a-share earnings beat with net interest margins up 52 basis points.

Top 10 Performing Stocks To Invest In Right Now: Laboratory Corporation of America Holdings(LH)

Advisors' Opinion:

• [By Joseph Griffin]

  Renaissance Technologies LLC trimmed its position in Laboratory Corp. of America Holdings (NYSE:LH) by 39.0% during the second quarter, according to its most recent 13F filing with the SEC. The fund owned 556,105 shares of the medical research company’s stock after selling 355,300 shares during the period. Renaissance Technologies LLC owned about 0.55% of Laboratory Corp. of America worth $99,838,000 as of its most recent filing with the SEC.

• [By Ethan Ryder]

  Laboratory Corp. of America Holdings (NYSE:LH) has been assigned a consensus rating of “Buy” from the eighteen ratings firms that are currently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and twelve have assigned a buy recommendation to the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $196.64.

• [By Shane Hupp]

  Triangle Securities Wealth Management lifted its stake in Laboratory Corp. of America Holdings (NYSE:LH) by 34.5% in the second quarter, HoldingsChannel.com reports. The fund owned 2,339 shares of the medical research company’s stock after purchasing an additional 600 shares during the period. Triangle Securities Wealth Management’s holdings in Laboratory Corp. of America were worth $420,000 as of its most recent filing with the Securities & Exchange Commission.

• [By Max Byerly]

  MUFG Americas Holdings Corp trimmed its stake in LabCorp (NYSE:LH) by 55.0% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 10,683 shares of the medical research company’s stock after selling 13,073 shares during the quarter. MUFG Americas Holdings Corp’s holdings in LabCorp were worth $1,728,000 as of its most recent filing with the Securities & Exchange Commission.

• [By Garrett Baldwin]

  If you're looking to get your share of a booming, global growth story, look no further than Laboratory Corp. of America Holdings  (NYSE: LH).

  The Burlington, North Carolina-based company operates the largest network of clinical laboratories in the world. Its U.S. network has 36 labs and processes 2.5 million lab tests every week.

• [By Joseph Griffin]

  Envestnet Asset Management Inc. reduced its position in shares of LabCorp (NYSE:LH) by 45.1% during the first quarter, HoldingsChannel.com reports. The fund owned 19,179 shares of the medical research company’s stock after selling 15,727 shares during the quarter. Envestnet Asset Management Inc.’s holdings in LabCorp were worth $3,116,000 at the end of the most recent reporting period.